Furthermore, TNF-α and IL-17A are thought to have synergistic tumor promoting properties when expressed together in CRC cells, whereby these cytokines stimulate glucose metabolism and growth factor production (38). This evidence concerns the gene IL17A and colorectal carcinoma.